Suppr超能文献

富氢生理盐水减轻肾缺血再灌注损伤。

Hydrogen-rich saline solution attenuates renal ischemia-reperfusion injury.

机构信息

Department of Anesthesiology and Intensive Care Medicine, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasamamachi, Yufu, Oita, 879-5593, Japan.

出版信息

J Anesth. 2010 Aug;24(4):569-74. doi: 10.1007/s00540-010-0942-1. Epub 2010 May 18.

Abstract

PURPOSE

Renal ischemia-reperfusion (I/R), an important cause of acute kidney injury, is unavoidable during various types of operations, including renal transplantation, surgical revascularization of the renal artery, partial nephrectomy, and treatment of suprarenal aortic aneurysms. Exacerbation of I/R injury is mediated by reactive oxygen species (ROS). A recent study has shown that hydrogen has antioxidant properties. In this study, we tested the hypothesis that a hydrogen-rich saline solution (HRSS) attenuates renal I/R injury in a rodent model.

METHODS

Rats were treated with an intravenous injection of HRSS or control saline solution followed by renal I/R. After 24 h of treatment, we performed a histological examination and transmission electron microscopy, and measured serum levels of 8-OHdG.

RESULTS

Histological analysis revealed a marked reduction of interstitial congestion, edema, inflammation, and hemorrhage in renal tissue harvested 24 h after HRSS treatment compared to saline administration. Renal I/R injury, which led to altered mitochondrial morphology, was also inhibited by HRSS. Furthermore, serum 8-OHdG levels were significantly lower in rats treated with HRSS and subjected to renal I/R.

CONCLUSIONS

These protective effects were likely due to the antioxidant properties of HRSS. These results suggest that HRSS is a potential therapeutic candidate for treating various I/R diseases.

摘要

目的

肾缺血再灌注(I/R)是急性肾损伤的一个重要原因,在各种手术中都不可避免,包括肾移植、肾动脉手术血运重建、部分肾切除术和治疗肾上腹主动脉瘤。活性氧(ROS)介导了 I/R 损伤的加重。最近的一项研究表明,氢气具有抗氧化特性。在本研究中,我们检验了富氢生理盐水(HRSS)是否能减轻啮齿动物模型中肾 I/R 损伤的假设。

方法

用静脉注射 HRSS 或对照生理盐水溶液处理大鼠,然后进行肾 I/R。治疗 24 小时后,我们进行了组织学检查和透射电镜检查,并测量了血清 8-OHdG 水平。

结果

与生理盐水给药相比,HRSS 治疗 24 小时后采集的肾组织中间质充血、水肿、炎症和出血明显减少。HRSS 还抑制了导致线粒体形态改变的肾 I/R 损伤。此外,接受 HRSS 和肾 I/R 的大鼠的血清 8-OHdG 水平明显降低。

结论

这些保护作用可能归因于 HRSS 的抗氧化特性。这些结果表明,HRSS 是治疗各种 I/R 疾病的潜在治疗候选药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验